1. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62(7):131–5.
2. The centers for disease control and prevention's public health response to monitoring Tdap safety in pregnant women in the United States;Moro;Hum Vaccin Immunother,2015
3. U.S. Food and Drug Administration. Tetanus Toxoid, Reduced Diptheria Toxoid and Accelular Pertussis Vaccine, Adsorbed. Adacel Package Insert. 2015 2-18-2015 [cited 2016 April 25]; Available from: http://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm142764.pdf.
4. U.S. Food and Drug Administration. Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed. Boostrix Package Insert. 2016 04-29-2016 [cited 2016 April 29]; Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/UCM152842.pdf.
5. A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix) is immunogenic and well tolerated in adults;Booy;Vaccine,2010